Brief: Lunit Inc - Collaboration With National Cancer Center Hospital East To Evaluate & Validate Its AI Pathology Solution For Tissue Data Analysis
May 30 (Reuters) - Lunit Inc 328130.KQ :
* LUNIT INC - COLLABORATION WITH NATIONAL CANCER CENTER
HOSPITAL
EAST TO EVALUATE & VALIDATE ITS AI PATHOLOGY SOLUTION FOR TISSUE
DATA ANALYSIS
Source text for Eikon: ID:nPn1Xmn0Ha
Further company coverage: 328130.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunit
See all newsBrief: Summit Therapeutics And Lunit Announce Agreement To Apply Ai-Powered Scope Io Platform For Tumor Microenvironment Analysis In Immuno-Oncology Development
Brief: Lunit Inc To Conduct Capital Increase Of 250 Billion Won
Brief: Lunit Announces Collaboration with Daiichi Sankyo on AI-Driven Biomarker Discovery
Brief: Lunit Inc - Awarded National Tender In France For Breast AI
Brief: Lunit Expands Partnership With Saudi Arabia's Largest Medical Group To Deploy Ai Chest X-Ray Solution